Darnell, R.B. & Warren, S.T. (2001) Microarray identification of
FMRP-associated brain mRNAs and altered mRNA translational
profiles in FraX syndrome. Cell 107, 477–487.
Buchs, P.-A. & Muller, D. (1996) Induction of long-term
potentiation is associated with major ultrastructural changes
of activated synapses. Proc Natl Acad Sci USA 93, 8040–8045.
Cairns, N.J. (2001) Molecular neuropathology of transgenic
mouse models of Down syndrome. J Neural Transm suppl
61, 289–301.
Cano, E., Canellada, A., Minami, T., Iglesias, T. & Redondo, J.M.
(2005) Depolarization of neural cells induces transcription of
the down syndrome critical region 1 isoform 4 via a calcineurin/
NFAT dependent pathway. J Biol Chem 280, 29435–29443.
Carthew, R.W. (2002) RNA interference: the FraX syndrome
connection. Curr Biol 12, R852–R854.
Ceman, S., O'Donnell, W.T., Reed, M., Patton, S., Pohl, J. &
Warren, S.T. (2003) Phosphorylation influences the translation
state of FMRP-associated polyribosomes. Hum Mol Genet 12,
3295–3305.
Chelly, J. & Mandel, J.L. (2001) Monogenic causes of X-linked
mental retardation. Nat Rev Genet 2, 669–680.
Chen-Hwang, M.C., Chen, H.R., Elzinga, M. & Hwang, Y.W.
(2002) Dynamin is a minibrain kinase/dual specificity Yak1related kinase 1A substrate. J Biol Chem 277, 17597–17604.
Chiurazzi, P. & Oostra, B.A. (2000) Genetics of mental retardation. Curr Opin Pediatr 12, 529–535.
Clark, D. & Wilson, G.N. (2003) Behavioral assessment of children with Down syndrome using the Reiss psychopathology
scale. Am J Med Genet 118, 210–216.
Comery, T.A., Harris, J.B., Willems, P.J., Oostra, B.A., Irwin, S.A.,
Weiler, I.J. & Greenough, W.T. (1997) Abnormal dendritic spines
in FraX knockout mice: maturation and pruning deficits. Proc Natl
Acad Sci USA 94, 5401–5404.
Cornish, K.M., Turk, J., Wilding, J., Sudhalter, V., Munir, F., Kooy, F.
& Hagerman, R. (2004) Annotation: deconstructing the
attention deficit in FraX syndrome: a developmental neuropsychological approach. J Child Psychol Psychiatry 45,
1042–1053.
Coyle, J.T., Oster-Granite, M.L. & Gearhart, J.D. (1986) The
neurobiologic consequences of Down syndrome. Brain Res
Bull 16, 773–787.
Curry, C.J., Stevenson, R.E., Aughton, D., Byrne, J., Carey, J.C.,
Cassidy, S., Cunniff, C., Graham, J.M. Jr, Jones, M.C.,
Kaback, M.M., Moeschler, J., Schaefer, G.B., Schwartz, S.,
Tarleton, J. & Opitz, J. (1997) Evaluation of mental retardation:
recommendations of a Consensus Conference: American
College of Medical Genetics. Am J Med Genet 72, 468–477.
Darnell, J.C., Jensen, K.B., Jin, P., Brown, V., Warren, S.T. &
Darnell, R.B. (2001) Fragile X mental retardation protein targets
G quartet mRNAs important for neuronal function. Cell 107,
489–499.
Darnell, J.C., Fraser, C.E., Mostovetsky, O., Stefani, G.,
Jones, T.A., Eddy, S.R. & Darnell, R.B. (2005) Kissing complex
RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes
Dev 19, 903–918.
De Boulle, K., Verkerk, A.J., Reyniers, E., Vits, L., Hendrickx, J.,
Van Roy, B., Van den Bos, F., de Graaff, E., Oostra, B.A.
& Willems, P.J. (1993) A point mutation in the FMR-1
gene associated with FraX mental retardation. Nat Genet 3,
31–35.
Diaz-Cintra, S., Cintra, L., Ortega, A., Kemper, T. & Morgane, P.J.
(1990) Effects of protein deprivation on pyramidal cells of the
